Tfg Advisers LLC Gilead Sciences, Inc. Transaction History

Tfg Advisers LLC

$274 Million
Q3 2024

A detailed history of Tfg Advisers LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Tfg Advisers LLC holds 3,173 shares of GILD stock, worth $284,015. This represents 0.1% of its overall portfolio holdings.

Number of Shares

3,173

Previous 3,184 0.35%

Holding current value

$284,015

Previous $218,000 21.56%

% of portfolio

0.1%

Previous 0.09%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 22, 2024	SELL	$66.59 - $83.99 $732 - $923	-11 Reduced 0.35%	3,173 $265,000
Q2 2024 Jul 25, 2024	BUY	$63.15 - $72.88 $1,641 - $1,894	26 Added 0.82%	3,184 $218,000
Q1 2024 May 06, 2024	SELL	$71.58 - $87.29 $3,865 - $4,713	-54 Reduced 1.68%	3,158 $231,000
Q4 2023 Feb 13, 2024	BUY	$73.27 - $83.09 $1,685 - $1,911	23 Added 0.72%	3,212 $260,000
Q3 2023 Oct 19, 2023	SELL	$73.94 - $80.67 $31,054 - $33,881	-420 Reduced 11.64%	3,189 $238,000
Q2 2023 Jul 19, 2023	SELL	$76.01 - $86.7 $28,579 - $32,599	-376 Reduced 9.44%	3,609 $278,000
Q1 2023 May 02, 2023	SELL	$77.31 - $88.08 $25,589 - $29,154	-331 Reduced 7.67%	3,985 $330,000
Q4 2022 Feb 01, 2023	BUY	$62.32 - $89.47 $6,668 - $9,573	107 Added 2.54%	4,316 $370,000
Q3 2022 Oct 21, 2022	BUY	$59.54 - $68.01 $4,346 - $4,964	73 Added 1.76%	4,209 $260,000
Q2 2022 Jul 20, 2022	SELL	$57.72 - $65.01 $1,558 - $1,755	-27 Reduced 0.65%	4,136 $256,000
Q1 2022 Apr 20, 2022	BUY	$57.92 - $72.58 $984 - $1,233	17 Added 0.41%	4,163 $247,000
Q4 2021 Feb 01, 2022	SELL	$64.88 - $73.64 $26,925 - $30,560	-415 Reduced 9.1%	4,146 $301,000
Q3 2021 Oct 21, 2021	SELL	$67.69 - $73.03 $46,706 - $50,390	-690 Reduced 13.14%	4,561 $319,000
Q2 2021 Jul 19, 2021	SELL	$63.47 - $69.35 $74,069 - $80,931	-1,167 Reduced 18.18%	5,251 $362,000
Q1 2021 Apr 23, 2021	SELL	$60.0 - $68.46 $2,460 - $2,806	-41 Reduced 0.63%	6,418 $415,000
Q4 2020 Feb 02, 2021	BUY	$56.65 - $64.55 $11,669 - $13,297	206 Added 3.29%	6,459 $376,000
Q3 2020 Nov 02, 2020	BUY	$62.1 - $78.08 $9,315 - $11,712	150 Added 2.46%	6,253 $395,000
Q2 2020 Aug 04, 2020	BUY	$72.34 - $84.0 $22,642 - $26,292	313 Added 5.41%	6,103 $469,000
Q1 2020 Apr 24, 2020	SELL	$62.63 - $80.22 $36,200 - $46,367	-578 Reduced 9.08%	5,790 $432,000
Q4 2019 Mar 16, 2020	BUY	$61.62 - $67.78 $492 - $542	8 Added 0.13%	6,368 $413,000
Q3 2019 May 01, 2020	BUY	$62.51 - $69.0 $3,438 - $3,795	55 Added 0.87%	6,360 $403,000
Q2 2019 May 01, 2020	BUY	$61.87 - $69.38 $15,467 - $17,345	250 Added 4.13%	6,305 $426,000
Q1 2019 Apr 30, 2020	SELL	$62.53 - $70.05 $4,064 - $4,553	-65 Reduced 1.06%	6,055 $393,000
Q4 2018 Apr 29, 2020	BUY	$60.54 - $79.0 $370,504 - $483,480	6,120 New	6,120 $382,000

Others Institutions Holding GILD

# of Institutions

1,903

Shares Held

1.02B

Call Options Held

12M

Put Options Held

9.02M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $112B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tfg Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tfg Advisers LLC with notifications on news.

Account